BOTHELL, Wash.--(BUSINESS WIRE)--Seagen Inc. (Nasdaq: SGEN) today announced the upcoming presentation of detailed results from two pivotal Phase 3 studies at the ESMO Congress 2023. Results from the ...
This release is also available in French, Spanish, German, and Italian. A new charitable foundation that will improve cancer care in Europe and beyond is being created by the European Society for ...
LUGANO, 6 SEPTEMBER, 2016 - Professor Sumitra Thongprasert has been awarded the second ESMO Women for Oncology award1, honouring her position as a role model for women in the profession and for her ...
– Late-breaking results from global Phase 3 confirmatory studies of PADCEV (EV-302) in locally advanced or metastatic bladder cancer and TIVDAK (innovaTV 301) in recurrent or metastatic cervical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results